News for 'food regulations'

Oh Maggi! Big question mark over fate of India's most popular noodles

Oh Maggi! Big question mark over fate of India's most popular noodles

Rediff.com21 May 2015

Is India's most popular instant noodles banned in Uttar Pradesh?

Make in India should move focus away from strong sectors, says NITI

Make in India should move focus away from strong sectors, says NITI

Rediff.com23 Jan 2017

NITI Aayog wants the prime minister's flagship initiative should focus on labour-intensive sectors and policies that impede their growth to get special attention.

'Made in India' dominates US AIDS scheme

'Made in India' dominates US AIDS scheme

Rediff.com16 Oct 2009

Indian drug companies have cornered an overwhelming majority of drug approvals under the US President's Emergency Plan for AIDS Relief.

Pulses race to Rs 200/kg; govt orders crackdown on hoarders

Pulses race to Rs 200/kg; govt orders crackdown on hoarders

Rediff.com16 Jun 2016

Markets regulator Sebi joined hands by banning any fresh futures market position in chana, the only commodity among pulses where such trading was allowed

'Rating agencies are like Bollywood'

'Rating agencies are like Bollywood'

Rediff.com11 Feb 2021

'Rather than cutting and pasting from advanced economies, we should use basic economic principles to think about what is right for India at the stage of development at which we are,' says Chief Economic Advisor Krishnamurthy Subramanian.

FIR filed against Snapdeal CEO, directors

FIR filed against Snapdeal CEO, directors

Rediff.com1 May 2015

In April, Snapdeal had said it was delisting the drugs from its portal and was assisting the regulator in the investigation.

Daiichi, Ranbaxy team to counter FDA charges

Daiichi, Ranbaxy team to counter FDA charges

Rediff.com27 Feb 2009

The USFDA has accused Ranbaxy of falsifying data and test results of medicines. A Daiichi Sankyo statement said it takes the issue very seriously. 'Both Daiichi and Ranbaxy have formed a team to solve the issue. Ranbaxy will be responding to the FDA and will continue to cooperate with the agency.' Ranbaxy shares fell more than 18 per cent to Rs 169.85 today on the Bombay Stock Exchange, while Daiichi stock dropped about 10 per cent to yen 1,680 on the Tokyo Stock Exchange.

Yasin Bhatkal is in habit of filing false complaints: Tihar

Yasin Bhatkal is in habit of filing false complaints: Tihar

Rediff.com25 Jul 2014

Indian Mujahideen co-founder Yasin Bhatkal is in a "habit of filing false complaints", the Tihar jail authority today told a Delhi court while responding to his plea in which he had alleged that he was being treated "worse than an animal" in the high security prison.

How safe are cheap medicines made in India?

How safe are cheap medicines made in India?

Rediff.com11 Mar 2016

An International Policy Network report in 2010 found that seven per cent of drugs bought from wholesale traders were substandard, and 3.6 per cent of the drugs from traders contained no active ingredient whatsoever.

Obama inks landmark anti-tobacco law

Obama inks landmark anti-tobacco law

Rediff.com23 Jun 2009

The law bans fruit and spice-flavoured cigarettes, slaps expansive new warnings on packages and gets rid of the monikers 'light' and 'low-tar'.

Saddened my voice in support of farmers was not heard: Harsimrat

Saddened my voice in support of farmers was not heard: Harsimrat

Rediff.com18 Sep 2020

She resigned soon after her husband and SAD president Sukhbir Singh Badal strongly opposed the bills in Lok Sabha on Thursday night, claiming these proposed legislations will "destroy" the agriculture sector in Punjab, and announced that Harsimrat Kaur Badal will quit the government in protest against these three bills.

US drops legal action against Ranbaxy

US drops legal action against Ranbaxy

Rediff.com10 Oct 2008

Ranbaxy's shares jumped almost 10 per cent, having long been depressed by escalating investigations from the US Food and Drug Administration, triggering a ban, which is still in place, that stops the US importing or purchasing the company's drugs. Daiichi Sankyo, the Japanese drugmaker, reiterated on Wednesday that it would stick to its June offer to buy Ranbaxy in spite of its recent troubles.

Obama's anti-tobacco bill, and its impact

Obama's anti-tobacco bill, and its impact

Rediff.com1 Jul 2009

US President Barack Obama has signed a historic bill that gives the government powers to curb advertising and promotion of tobacco products.

Taro faces ban on products in US market

Taro faces ban on products in US market

Rediff.com11 Feb 2009

If Taro fails to address the issues raised by the US Food and Drug Administration, it may face ban on many of its products in the US market, made from the facility at Ontorio, Canada. If Taro fails to address the issues raised by the US Food and Drug Administration, it may face ban on many of its products in the US market, made from the facility at Ontorio, Canada. If Taro fails to address the issues raised by the US FDA, it may face ban on many of its products.

PM to attend G-20 meet in Japan from June 28-29

PM to attend G-20 meet in Japan from June 28-29

Rediff.com21 Jun 2019

Former Union minister Suresh Prabhu would be India's Sherpa at the 14th meeting of the world's top economies in Osaka, Japan.

Maggi ban sent disturbing message to investors: Swiss envoy

Maggi ban sent disturbing message to investors: Swiss envoy

Rediff.com18 Nov 2015

It was a disturbing message in the sense that the regulatory framework is not clear enough and is not always applied in a convincing manner.

7 Indian pharma players race to develop COVID-19 vaccine

7 Indian pharma players race to develop COVID-19 vaccine

Rediff.com19 Jul 2020

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.

Nestle cancels leaves over Maggi recall

Nestle cancels leaves over Maggi recall

Rediff.com9 Jun 2015

The Indian part of the Swiss group employs more than 5,000.

60,000 Maggi kits sold out in 5 minutes on Snapdeal!

60,000 Maggi kits sold out in 5 minutes on Snapdeal!

Rediff.com12 Nov 2015

60,000 Maggi kits sold out in 5 minutes on Snapdeal!

Malls, hotels, religious places open as Unlock 1 begins

Malls, hotels, religious places open as Unlock 1 begins

Rediff.com9 Jun 2020

As the number of cases crossed 2,56,000 with more than 7,100 fatalities, according to Union health ministry figures, and the country made a calibrated exit from the lockdown in non-containment zones, shop shutters in many malls went up for the first time since March 25 but the sprawling retail places were eerily empty.

Ponzi schemes: Govt orders SFIO to probe 187 companies

Ponzi schemes: Govt orders SFIO to probe 187 companies

Rediff.com3 May 2016

Probe has been completed against 83.

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

Rediff.com24 Jun 2013

FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.

India may sign WTO's Trade Facilitation Agreement

India may sign WTO's Trade Facilitation Agreement

Rediff.com10 Nov 2014

The study paper by Melbourne-based think-tank Australia India Institute titled 'The G20: Challenges and opportunities Ahead', said following Prime Minister Narendra Modi's visit to the US and his talks with US President Barack Obama, India may finally sign the agreement.

5 sex myths busted in 2017!

5 sex myths busted in 2017!

Rediff.com30 Dec 2017

It's time to bust stereotypes.

What is ailing India's pharma sector?

What is ailing India's pharma sector?

Rediff.com18 Aug 2016

Low growth visibility and trouble with regulators have resulted in lack of interest from investors

Dr Reddy's launch generic cancer drug in US market

Dr Reddy's launch generic cancer drug in US market

Rediff.com12 Jul 2013

The company has launched the Decitabine for injection in the strength of 50 mg in the US market following approval by the United States Food & Drug Administration of Dr Reddy's abbreviated new drug applications, it said in a statement.

'The inflation momentum is coming down'

'The inflation momentum is coming down'

Rediff.com10 Sep 2008

While making it clear he will continue with the strategy followed by RBI so far on inflation and exchange rate management, RBI Governor D Subbarao said, "We will be monitoring the situation closely and continuously, be mindful of implications of our monetary stance on the growth prospects and take action as appropriate." He added, "I am not sure whether we can say inflation is softening consistently, but the decline in the Wholesale Price Index is satisfying."

Alembic seeks allies in US to double sales

Alembic seeks allies in US to double sales

Rediff.com8 Sep 2008

The Rs 1,027-crore (Rs 10.27 billion) company has filed 13 abbreviated new drug applications and 22 drug master files with the US Food and Drug Administration and regulatory agencies in Europe for supply of formulations and active pharmaceutical ingredients. Some of the ANDAs challenge innovator patents and the company's strategy will be to partner with established companies in the US and Europe for marketing formulations, said Pranav Amin, director, Alembic.

Oil from cannabis seed is the new elixir

Oil from cannabis seed is the new elixir

Rediff.com25 Jan 2020

CBD oil, found in marijuana, is gaining popularity for its pain-relieving properties. It's now legally available in India

What Modi got wrong about the economy

What Modi got wrong about the economy

Rediff.com18 Dec 2019

'There has been far too much overconfidence about the size and composition of the Indian consumer economy,' notes Mihir S Sharma.

« Prev  |